Compare Amphastar Pharmaceuticals Inc (AMPH) vs Zillow Group Inc Class A (ZG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Zillow Group Inc Class A — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while Zillow Group Inc Class A trades at $34.27 (market cap $7.68B). The key difference: Zillow Group Inc Class A is far larger — about 8.8× Amphastar Pharmaceuticals Inc's market cap, and Amphastar Pharmaceuticals Inc is trading nearer its 52-week high, Zillow Group Inc Class A nearer its low. Which is the better fit depends on your goals.
| AMPH | ZG | |
|---|---|---|
Market Cap | $868.62M | $7.68B |
Sector | Health | Media |
52-Week High | $30.81 | $86.76 |
52-Week Low | $16.87 | $29.14 |
Enterprise Value | $1.27B | $7.56B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Zillow Group Inc Class A
Zillow Group is an Internet-based real estate company that has historically focused on deriving ad revenue from third-party brokers on online marketplaces such as Zillow.com, Trulia, and HotPads. More recently it has shifted its focus to iBuying via the Zillow Offers platform.
Read more on ZG →
